一种用于糖尿病性脂肪肝的中药复方制剂制造技术

本发明专利技术公开了一种用于糖尿病性脂肪肝的中药复方制剂，该制剂是由当归、白术、柴胡、党参、太子参、白芥子、黄连、山药、延胡索、石斛、青皮共十一味中草药为原料，在传统的中医辨证治疗的基础上结合现代最新科研成果研制而成的。具有活血通络、健脾益气、清热解毒、疏肝消积之功效，疗效确切、安全方便、无毒副作用，适用于糖尿病性脂肪肝患者的用药治疗。

Traditional Chinese medicine compound preparation for diabetic fatty liver

The invention discloses a Chinese medicine compound preparation for treating diabetic fatty liver, the preparation is made from angelica, Atractylodes, bupleurum, Radix Codonopsis, Radix Pseudostellariae, white mustard seed, Rhizoma Coptidis, yam, Rhizoma Corydalis, Dendrobium, a total of eleven kinds of green herbs as raw materials, based on the traditional Chinese medicine diagnosis and treatment developed with the latest modern scientific achievements. It has the effect of activating blood circulation and dredging collaterals, invigorating spleen and replenishing qi, clearing away heat and toxic substances, soothing liver and eliminating accumulation. The curative effect is exact, safe and convenient, non-toxic and side effects. It is suitable for the treatment of diabetic fatty liver patients.

【技术实现步骤摘要】

【技术保护点】
一种用于糖尿病性脂肪肝的中药复方制剂，其特征在于它包括重量单位按ｇ计的以下中药为原料制得的：　当归８０～１５０ｇ　白术６０～１００ｇ　柴胡６０～１００ｇ　党参３０～８０ｇ　太子参２０～６０ｇ　白芥子６０～１００ｇ　 黄连８０～１５０ｇ　山药３０～８０ｇ　延胡索６０～１００ｇ　石斛６０～１００ｇ　青皮８０～１５０ｇ。

【技术特征摘要】

【专利技术属性】
技术研发人员：伍荣林，
申请(专利权)人：北京天科仁祥医药科技有限公司，
类型：发明
国别省市：11[中国|北京]